Status:
RECRUITING
Role of the Immune Environment in Response to Therapy in Breast Cancer
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Breast Cancer
ER Positive Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
- Exclusion criteria:
- Males Children Pregnant individuals
Exclusion
Key Trial Info
Start Date :
October 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05396612
Start Date
October 3 2022
End Date
December 31 2032
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104